Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1 to 15 of 1358 results for patients and public

  1. Patient and public involvement policy

    NICE's approach to patient and public involvement is based on 2 key principles: that lay people, and organisations...

  2. Patient group directions (MPG2)

    This guideline covers good practice for developing, authorising, using and updating patient group directions. It also offers advice on deciding whether a patient group direction is needed.

    Medicines practice guideline
    Last updated
    27 March 2017
    View recommendations

    Sections for MPG2

  3. Public Involvement Programme

    use services, carers, members of the public and organisations who represent their interests across NICE. Our public...

  4. Patient experience in adult NHS services: improving the experience of care for people using adult NHS services (CG138)

    This guideline covers the components of a good patient experience. It aims to make sure that all adults using NHS services have the best possible experience of care.

    Clinical guideline
    Last updated
    17 June 2021
    View recommendations

    Sections for CG138

  5. Public board meeting agenda and papers: September 2021

    Agenda and papers of the NICE public board meeting on 15 September 2021

  6. Public involvement - putting you at the heart of our work

    advice. We're committed to involving people who use services, carers and the public in the development of our guidance and other...

  7. Public board meeting agenda and papers: September 2023

    Agenda and papers of the NICE public board meeting on 21 September 2023

  8. Public board meeting agenda and papers: November 2020

    Agenda and papers of the NICE public board meeting on 18 November 2020

  9. The NICE public health guidance development process (third edition) (PMG5)

    The NICE public health guidance development process (third edition)

  10. Methods for the development of NICE public health guidance (third edition) (PMG4)

    Methods for the development of NICE public health guidance (third edition)

  11. Information for the public on medicines

    enough to be used for a specific condition and for a specific group of patients, and that they can manufacture the medicine to the...

  12. Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma [Review of TA540] [ID5084]

    In development [GID-TA11317] Expected publication date: 01 May 2024

    Technology appraisal guidance
    In development

  13. Making Every Contact Count for Physical Activity in Musculoskeletal Outpatient Physiotherapy: A service improvement project to implement NICE public health guidance PH44

    these recommendations making the region one of the least active in England (Public Health England, 2016). Many physiotherapists discuss...

    Shared learning
    Published
    5 April 2018

  14. Remdesivir and tixagevimab plus cilgavimab for treating COVID-19 [ID6261]

    In development [GID-TA11297] Expected publication date: 08 May 2024

    Technology appraisal guidance
    In development

  15. Standards framework for shared-decision-making support tools, including patient decision aids (ECD8)

    This framework sets out a series of standards to support people using patient decision aids (PDAs) in assessing the usefulness and quality of a PDA